Literature DB >> 12163605

Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma.

Angela Malaspina1, Susan Moir, David C Nickle, Eileen T Donoghue, Kisani M Ogwaro, Linda A Ehler, Shuying Liu, Jo Ann M Mican, Mark Dybul, Tae-Wook Chun, James I Mullins, Anthony S Fauci.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) virions bind to B cells in the peripheral blood and lymph nodes through interactions between CD21 on B cells and complement-complexed virions. B-cell-bound virions have been shown to be highly infectious, suggesting a unique mode of HIV-1 dissemination by B cells circulating between peripheral blood and lymphoid tissues. In order to investigate the relationship between B-cell-bound HIV-1 and viruses found in CD4+ T cells and in plasma, we examined the genetic relationships of HIV-1 found in the blood and lymph nodes of chronically infected patients with heteroduplex mobility and tracking assays and DNA sequence analysis. In samples from 13 of 15 patients examined, HIV-1 variants in peripheral blood-derived B cells were closely related to virus in CD4+ T cells and more divergent from virus in plasma. In samples from five chronically viremic patients for whom analyses were extended to include lymph node-derived HIV-1 isolates, B-cell-associated HIV-1 and CD4+-T-cell-associated HIV-1 in the lymph nodes were equivalent in their divergence from virus in peripheral blood-derived B cells and generally more distantly related to virus in peripheral blood-derived CD4+ T cells. These results indicates virologic cross talk between B cells and CD4+ T cells within the microenvironment of lymphoid tissues and, to a lesser extent, between cells in lymph nodes and the peripheral blood. These findings also indicate that most of the virus in plasma originates from cells other than CD4(+) T cells in the peripheral blood and lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163605      PMCID: PMC136413          DOI: 10.1128/jvi.76.17.8855-8863.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes.

Authors:  J J Jakubik; M Saifuddin; D M Takefman; G T Spear
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

Authors:  T W Chun; R T Davey; M Ostrowski; J Shawn Justement; D Engel; J I Mullins; A S Fauci
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

3.  Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2.

Authors:  L Kacani; W M Prodinger; G M Sprinzl; M G Schwendinger; M Spruth; H Stoiber; S Döpper; S Steinhuber; F Steindl; M P Dierich
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.

Authors:  R T Davey; N Bhat; C Yoder; T W Chun; J A Metcalf; R Dewar; V Natarajan; R A Lempicki; J W Adelsberger; K D Miller; J A Kovacs; M A Polis; R E Walker; J Falloon; H Masur; D Gee; M Baseler; D S Dimitrov; A S Fauci; H C Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice.

Authors:  J G Tew; T E Mandel
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

Review 6.  Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.

Authors:  A T Haase
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

7.  Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection.

Authors:  J A Nelson; F Baribaud; T Edwards; R Swanstrom
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.

Authors:  M E Quiñones-Mateu; S C Ball; A J Marozsan; V S Torre; J L Albright; G Vanham; G van Der Groen; R L Colebunders; E J Arts
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen.

Authors:  L H Ping; M S Cohen; I Hoffman; P Vernazza; F Seillier-Moiseiwitsch; H Chakraborty; P Kazembe; D Zimba; M Maida; S A Fiscus; J J Eron; R Swanstrom; J A Nelson
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

10.  B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.

Authors:  S Moir; A Malaspina; Y Li; T W Chun; T Lowe; J Adelsberger; M Baseler; L A Ehler; S Liu; R T Davey; J A Mican; A S Fauci
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more
  12 in total

Review 1.  A review of quantitative modeling of B cell responses to antigenic challenge.

Authors:  Timothy P Hickling; Xiaoying Chen; Paolo Vicini; Satyaprakash Nayak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-19       Impact factor: 2.745

Review 2.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

3.  Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status.

Authors:  Sharon T Sullivan; Usha Mandava; Tammy Evans-Strickfaden; Jeffrey L Lennox; Tedd V Ellerbrock; Clyde E Hart
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 4.  Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  J Allergy Clin Immunol       Date:  2008-06-10       Impact factor: 10.793

Review 5.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

6.  HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites.

Authors:  Nitin K Saksena; Bin Wang; Li Zhou; Maly Soedjono; Yung Shwen Ho; Viviane Conceicao
Journal:  HIV AIDS (Auckl)       Date:  2010-06-15

7.  Direct phenotypical and functional dysregulation of primary human B cells by human immunodeficiency virus (HIV) type 1 in vitro.

Authors:  Ana Judith Perisé-Barrios; María Ángeles Muñoz-Fernandez; Marjorie Pion
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

8.  Simian Immunodeficiency Virus Susceptibility, Immunology, and Microbiome in the Female Genital Tract of Adolescent Versus Adult Pigtail Macaques.

Authors:  Alicia R Berard; Charlene Miller; Mariluz Araínga; Courtney Ann Broedlow; Laura Noël-Romas; Luca Schifanella; Tiffany Hensley-McBain; Alex Roederer; Connor B Driscoll; Ernesto Coronado; Jennifer Manuzak; Lyle R McKinnon; Francois Villinger; Thomas J Hope; Adam D Burgener; Nichole R Klatt
Journal:  AIDS Res Hum Retroviruses       Date:  2021-06-22       Impact factor: 1.723

9.  DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes.

Authors:  Giovanna Rappocciolo; Paolo Piazza; Craig L Fuller; Todd A Reinhart; Simon C Watkins; David T Rowe; Mariel Jais; Phalguni Gupta; Charles R Rinaldo
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

Review 10.  Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection.

Authors:  Maria R Petrara; Riccardo Freguja; Ketty Gianesin; Marisa Zanchetta; Anita De Rossi
Journal:  Front Microbiol       Date:  2013-10-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.